CIRILLO, PLINIO
 Distribuzione geografica
Continente #
AS - Asia 9.312
NA - Nord America 7.591
EU - Europa 5.908
SA - Sud America 1.183
AF - Africa 218
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.226
Nazione #
US - Stati Uniti d'America 7.277
SG - Singapore 4.324
RU - Federazione Russa 2.645
CN - Cina 1.676
VN - Vietnam 1.614
IT - Italia 1.031
BR - Brasile 942
HK - Hong Kong 808
DE - Germania 398
FR - Francia 375
NL - Olanda 279
FI - Finlandia 270
IE - Irlanda 203
CA - Canada 189
BD - Bangladesh 167
SE - Svezia 157
JP - Giappone 142
GB - Regno Unito 140
UA - Ucraina 140
IN - India 129
AR - Argentina 99
MX - Messico 64
ZA - Sudafrica 62
IQ - Iraq 60
KR - Corea 57
PL - Polonia 46
ID - Indonesia 45
EC - Ecuador 44
ES - Italia 40
TH - Thailandia 38
CI - Costa d'Avorio 37
AT - Austria 36
PH - Filippine 36
BG - Bulgaria 30
CO - Colombia 28
PK - Pakistan 28
TR - Turchia 27
MA - Marocco 22
TW - Taiwan 22
PY - Paraguay 20
EG - Egitto 19
UZ - Uzbekistan 17
VE - Venezuela 17
CZ - Repubblica Ceca 16
BE - Belgio 15
AE - Emirati Arabi Uniti 14
CH - Svizzera 14
KE - Kenya 14
TN - Tunisia 14
JM - Giamaica 13
LT - Lituania 13
SA - Arabia Saudita 13
CL - Cile 12
IR - Iran 10
MY - Malesia 10
AL - Albania 9
TT - Trinidad e Tobago 9
BH - Bahrain 8
ET - Etiopia 8
GT - Guatemala 8
JO - Giordania 8
PE - Perù 8
PT - Portogallo 8
RO - Romania 8
DZ - Algeria 7
KZ - Kazakistan 7
OM - Oman 7
UY - Uruguay 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
BO - Bolivia 5
HN - Honduras 5
LB - Libano 5
NZ - Nuova Zelanda 5
AZ - Azerbaigian 4
BY - Bielorussia 4
GA - Gabon 4
IL - Israele 4
NG - Nigeria 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
BW - Botswana 3
CW - ???statistics.table.value.countryCode.CW??? 3
KG - Kirghizistan 3
MD - Moldavia 3
MT - Malta 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
BB - Barbados 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
Totale 24.172
Città #
Singapore 1.992
San Jose 1.172
Hong Kong 789
Moscow 691
Chandler 544
Ashburn 493
Ho Chi Minh City 480
Beijing 379
Hanoi 372
Santa Clara 338
The Dalles 279
Amsterdam 238
Hefei 232
Millbury 230
Lauterbourg 228
Princeton 202
Los Angeles 201
Naples 195
Nanjing 183
Jacksonville 151
Boston 146
Buffalo 126
New York 125
Tokyo 121
Munich 113
Napoli 101
Wilmington 100
Ottawa 84
Redondo Beach 83
São Paulo 76
Council Bluffs 73
Da Nang 68
Des Moines 68
Dallas 63
Haiphong 61
Orem 60
Frankfurt am Main 51
Rome 51
Nanchang 50
Lawrence 41
Milan 41
Seoul 41
Dublin 40
Nuremberg 39
Seattle 38
Helsinki 37
Rio de Janeiro 37
Chicago 36
Denver 36
Hebei 35
Shenyang 34
Brooklyn 33
Houston 33
Turku 33
Warsaw 33
Atlanta 32
Montreal 29
Norwalk 29
Mexico City 28
Toronto 28
Chennai 27
Belo Horizonte 26
Sofia 26
Johannesburg 25
Boardman 24
Jiaxing 24
London 24
Tianjin 24
Kronberg 23
Baghdad 22
San Francisco 21
Afragola 20
Changsha 20
Dong Ket 20
Hải Dương 20
Biên Hòa 19
Phoenix 19
Falls Church 18
Kunming 18
Stockholm 18
Can Tho 17
Poplar 17
Quito 17
Vienna 17
Augusta 16
Brasília 16
Guangzhou 15
New Delhi 15
Tashkent 15
Bangkok 14
Charlotte 14
Manchester 14
Thái Bình 14
Bến Tre 13
Nairobi 13
Pune 13
Woodbridge 13
Guarulhos 12
Redwood City 12
Salvador 12
Totale 12.469
Nome #
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 176
True double bifurcation lesions: new application of the self-expandable Axxess stent and review of literature with dedicated bifurcation devices 176
Nicotine induces tissue factor expression in cultured endothelial and smooth muscle cells. 171
Protective role of chronic ubiquinone administration on acute cardiac oxidative stress. 170
Fructose induces prothrombotic phenotype in human endothelial cells: A new role for “added sugar” in cardio-metabolic risk 166
Moderate to severe mitral regurgitation in patients undergoing trancatheter aortic valve replacement: a meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,933 patients 161
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion 149
Management of Intraventricular Gradient in Patients With Aortic Stenosis 148
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 146
B1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure: Protective Role of S1PR1 Cardiac Gene Therapy 145
Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt–NF-κB axis 144
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 143
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 143
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 143
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 143
Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection? 143
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 141
Predictors of adherence to composite therapy after acute coronary syndromes 140
Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome 138
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 137
Quinacrine as a Novel Anti-Restenotic and Anti-Thrombotic Drug for Coronary Artery Interventions. 137
Anorexia nervosa-related cardiopathy in children with physical instability: prevalence, echocardiographic characteristics and reversibility at mid-term follow-up 137
Quantitative detection of inducible ischemia during dobutamine stress by speckle tracking echocardiography: A dream comes true 136
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 136
Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB 135
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 135
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 134
A New Approach to Percutaneous Coronary Revascularization in Patients Requiring Undeferrable Non Cardiac Surgery. 134
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial 134
Human heart shifts from IGF-1 production to utilization with chronic heart failure 132
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 130
Prevenzione della restenosi e della trombosi intrastent: ruolo del derivato acridinico quinacrina 130
Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis. 128
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 127
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 126
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 126
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 125
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 124
Accuracy of global and regional longitudinal strain at peak of dobutamine stress echocardiography to detect significant coronary artery disease 124
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 123
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 122
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 122
Angiographic improvement in STEMI reperfusion: a single centre experience 122
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 121
Quinacrine as a novel drug in the prevention of in-stent restenosis and thrombosis. 121
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction 120
Abluminal-Coated Drug-Eluting Bifurcation-Dedicated Stent for the Treatment of Tibioperoneal Bifurcation 120
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel 119
Recombinant Human, Active Site-Blocked Factor VIIa Reduces Infarct Size And The No-Reflow Phenomenon In A Rabbit Model Of Myocardial Ischemia And Reperfusion. 117
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 117
Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery 117
Effects of Hypobaric Hypoxia on Endothelial Function and Adiponectin Levels in Airforce Aviators 117
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 117
Ruolo del derivato acridinico Quinacrina nella prevenzione della restenosi e della trombosi intrastent. 116
Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome 116
L'aumento dei livelli di high mobility group box-1 protein (HMGB1) è associato a riduzione dei parametri cardiopolmonari ed ecocardiografici dopo infarto miocardico acuto 115
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 115
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation 114
A short burst of oxygen radicals at reflow induces sustained release of oxidized glutathione from postischemic hearts. 113
Pharmacotherapeutic Considerations for the Use of Prasugrel and Ticagrelor to Reduce Stent Thrombosis in Patients With Acute Coronary Syndrome. 113
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 113
Long term combination treatment for severe idiopathic pulmonary arterial hypertension 112
Independent association of longitudinal strain of left anterior ascending artery territory and TIMI frame count after acute anterior STEMI 112
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 111
Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1 111
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 111
La resistina è un’ adipocitochina in grado di indurre l’ espressione del fattore tissutale da parte di cellule endoteliali prelevate da arterie coronariche umane. 110
Percutaneous approach to treatment of coronary disease in a patient with uremic cardiomyopathy. 109
Local cytokine production in patients with Acute Coronary Syndromes: A look into the eye of the perfect (cytokine) storm 109
Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, experimental/clinical evidences and potential therapeutic approaches 109
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 109
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 108
Latent left ventricular ouflow tract obstruction induced by abnormal hypertrophic papillary muscle caused myocardial ischemia. 108
Vitamin D inhibits Tissue Factor and CAMs expression in oxidized low-density lipoproteins-treated human endothelial cells by modulating NF-κB pathway 108
The pitfalls of managing thrombosis of an Absorb?-treated bifurcation 107
Reperfusion Correlates and Clinical Outcomes of Right Ventricular Dysfunction in Patients With Inferior ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention 107
Mid-term outcomes after percutaneous interventions in coronary bifurcations 107
Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes 107
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction 106
High Mobility Group Box-1 protein as early marker of heart failure in patients with acute myocardial infarction 106
La leptina induce la produzione di Proteina C-Reattiva in cellule endoteliali coronariche umane. 105
Treatment of residual type A aortic dissection with implantation of the Djumbodis system: is purely endovascular treatment becoming a reality? 105
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes 104
Invasive Assessment of Coronary Microcirculation: A State-of-the-Art Review 104
Long-Lasting Antithrombotic Effects Of A Single Dose Of Human Recombinant, Active Site-Blocked Factor VII: Insights Into Possible Mechanism(S) Of Action. 104
Exercise training prevents left ventricular remodeling, reduces NT-pro-BNP and improves cardiovascular function in patients with acute myocardial infarction and moderate left ventricular dysfunction 104
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 104
Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome. 103
Pro-atherothrombotic effects of leptin in human coronary endothelial cells. 102
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 101
Induction of tissue factor in the arterial wall during recurrent thrombus formation 101
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 99
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries. 99
Induction of tissue factor in the arterial wall during recurrent thrombus formation 98
Nicotine induces Tissue Factor expression in cultured endothelial and smooth muscle cells. 98
Acquired Left Coronary Artery Fistula Draining to Cardiac Vein System after Acute Myocardial Infarction Revealed by CT-Scan. 97
Von Willebrand Factor and cardiovascular disease: from a biochemical marker to an attractive therapeutic target 97
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 96
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 96
Impact of drug-eluting stents on left ventricular wall motion after successful reperfusion of first anterior ST elevation myocardial infarction 96
Totale 12.183
Categoria #
all - tutte 84.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.168 18 5 15 9 13 79 20 45 242 25 138 559
2022/20231.486 253 98 32 110 187 133 11 114 200 239 80 29
2023/2024968 45 171 108 59 33 73 27 84 38 13 204 113
2024/20256.375 337 516 16 51 180 259 699 410 612 632 2.124 539
2025/202612.096 1.244 884 1.169 1.077 2.022 556 1.277 797 1.693 753 336 288
2026/2027400 400 0 0 0 0 0 0 0 0 0 0 0
Totale 24.549